[EN] PREPARATION OF SUBSTITUTED-4,5-DIHYDROPYRROLO[4,3,2-de][2,6]NAPHTHYRIDIN-3(1H)-ONES [FR] PRÉPARATION DE 4,5-DIHYDROPYRROLO[4,3,2-DE][2,6]NAPHTYRIDIN-3(1H)-ONES SUBSTITUÉES
[EN] PREPARATION OF SUBSTITUTED-4,5-DIHYDROPYRROLO[4,3,2-de][2,6]NAPHTHYRIDIN-3(1H)-ONES [FR] PRÉPARATION DE 4,5-DIHYDROPYRROLO[4,3,2-DE][2,6]NAPHTYRIDIN-3(1H)-ONES SUBSTITUÉES
[EN] PREPARATION OF SUBSTITUTED-4,5-DIHYDROPYRROLO[4,3,2-de][2,6]NAPHTHYRIDIN-3(1H)-ONES<br/>[FR] PRÉPARATION DE 4,5-DIHYDROPYRROLO[4,3,2-DE][2,6]NAPHTYRIDIN-3(1H)-ONES SUBSTITUÉES
申请人:TAKEDA PHARMACEUTICAL
公开号:WO2012078802A1
公开(公告)日:2012-06-14
Disclosed are materials and methods for preparing substituted 4,5-dihydropyrrolo[4,3,2-de][2,6]naphthyridin-3(1H)-ones of formula (1), Compounds of formula (1) inhibit one or more members of the Janus Kinase (JAK) family of cytoplasmic protein tyrosine kinases, and are useful for treating disorders, diseases, and conditions associated with the immune system, inflammation, and abnormal cell growth.